4-Chlorophenylglyoxal hydrate

Catalog No. :
ACAUZT478
CAS No. :
4996-21-8
Molecular Formula :
C8H7ClO3
Molecular Weight :
186.59

IUPAC Name:2-(4-chlorophenyl)-2-oxoacetaldehyde hydrate

4-Chlorophenylglyoxal hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$86.00Login to see priceIn stockInquiry
5g97%$303.00Login to see priceIn stockInquiry
10g97%$528.00Login to see priceIn stockInquiry
25g97%$1057.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chlorophenylglyoxal hydrate
IUPAC Name2-(4-chlorophenyl)-2-oxoacetaldehyde hydrate
MDL No.MFCD08272327
Molecular FormulaC8H7ClO3
Molecular Weight186.59
SMILESO=CC(C1=CC=C(Cl)C=C1)=O.[H]O[H]
InChI KeyJTOCXCVDVKZPEB-UHFFFAOYSA-N
Synonym4-chlorophenylglyoxal hydrate | 4996-21-8 | 859932-64-2 | 2-(4-chlorophenyl)-2-oxoacetaldehyde hydrate | 4-chlorophenyl glyoxal hydrate | 2-(4-chlorophenyl)-2-oxoacetaldehyde;hydrate | MFCD08272327 | 4-chlorophenylglyoxal monohydrate | SCHEMBL10353718 | AMY31336 | AKOS015855
CAS No.4996-21-8
PubChem CID15556731

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACAUZT478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCRN096 route compound structure diagram
    ACBCRN09622840-91-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAUZT478 route product structure diagram
    ACAUZT4784996-21-8 In Stock
Inquiry

2. ACAUZT478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAUZT478 route product structure diagram
    ACAUZT4784996-21-8 In Stock
Inquiry

Comments (0)